Media
Read our latest media releases, news and stories to find out what we’re doing and where.
Centrient Pharmaceuticals to boost statins manufacturing capacity
Doubling our API capacity to meet the growing demand for high-quality Atorvastatin and Rosuvastatin
read more
Penicillin laid the foundation for modern healthcare
With the discovery and large-scale production of antibiotics like penicillin, a wide range of bacterial infections were no longer considered life-threatening, driving a sharp increase in global life expectancy during the second half of the twentieth century.
read more
Driving transparency through serialisation
As one of the first generic pharmaceutical companies to have an IT system in place, we support our customers and partners with their own implementation processes.
read moreCentrient Pharmaceuticals Receives Gold Sustainability Rating from EcoVadis
read more
Building careers with Mexico’s refugees
As part of our effort to help people the communities where we work, we are helping to change the lives of refugees in Mexico.
read more
At Centrient, young professionals can make a difference
Rani Krisnamurthi, Product Marketing Manager at Centrient Pharmaceuticals in the Netherlands
read more
A sustainable supply chain for antibiotics
Combating antimicrobial resistance (AMR) means looking beyond our immediate horizons and working as part of the wider pharmaceutical value chain to effect change.
read more
STEM programme
We are working to raise awareness of antimicrobial resistance (AMR), and establish best practice in the regions where it’s needed most.
read more
Environmental impact
At Centrient, we take our environmental responsibilities extremely seriously. Because there is no other way.
read more
Sustainable procurement
Our responsibility to drive sustainability doesn’t stop with our own operations and processes.
read more
Clean antibiotics
We are paving the way for sustainable antibiotics and are a leading advocate of clean production practices.
read moreCentrient Pharmaceuticals Initiates a Second Patent Litigation in India Against Dalas Biotech Limited
read more
media@centrient.com